ADENOSINE INJECTION
Google image searchProduct monograph
Active ingredient
adenosine, 3 MG/ML
DIN: 02457474
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: 6 MG/ 2 ML PREFILLED SYRINGE. SINGLE USE.
Schedule: Prescription
Company: FRESENIUS KABI CANADA LTD
Date: 17-AUG-2017
ATC:
- C01 — CARDIAC THERAPY (ATC, ATC/DDD, )
- C01E — OTHER CARDIAC PREPARATIONS (ATC, ATC/DDD)
- C01EB — Other cardiac preparations (ATC, ATC/DDD)
- C01EB10 — ADENOSINE (ATC/DDD)
Reference brand drug: Adenocard
Pharmaceutical standard: USP
